A Clinical Pharmacy Perspective on Drug Utilization and Prescribing Practices in Gastroenterology

The present prospective observational study evaluated the prescription pattern of drugs among patients attending the gastroenterology outpatient department of a tertiary care hospital. A total of 100 prescriptions were assessed over a six-month study period. Patient demographic characteristics, diagnosis, comorbidities, prescribed medicines, number of drugs, duration of therapy, dietary advice, follow-up advice, adverse reactions and lifestyle advice were recorded. Descriptive statistics were used and findings were expressed as frequencies and percentages. Patients aged 46–60 years constituted the largest age group (31%), followed by those above 60 years (28%) and 31–45 years (27%). Females represented 49% and males 51% of the study population. Normal body mass index was recorded in 71% of patients. Gastroesophageal reflux disease was the most frequent listed primary diagnosis (7%). Most patients (58%) received one to two drugs per prescription, while 21% received three to four, 14% received five to six and 7% received more than six drugs. Proton pump inhibitors were the most commonly reported drug category (26%), followed by gastrointestinal prokinetic agents (14%). Therapy continued for more than 30 days in 36% of prescriptions. Comorbidities were absent in 95% of patients. Follow-up was advised in 82%, while adverse reactions were reported in 1% of patients. Dietary advice was not documented in 62% of prescriptions, whereas 26% included a soft diet. The findings demonstrate predominant use of acid-suppressive therapy and variable degrees of polypharmacy, supporting the need for continued prescription review and rational drug-use monitoring in gastroenterology practice.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414343
Primary Topic
Pharmaceutical Practices and Patient Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A Clinical Pharmacy Perspective on Drug Utilization and Prescribing Practices in Gastroenterology

N. Firdous, M. D. Shahabaz Alam, S. Babu, C. Navaneetha et al.
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Practices and Patient Outcomes
article

A Clinical Pharmacy Perspective on Drug Utilization and Prescribing Practices in Gastroenterology

N. Firdous, M. D. Shahabaz Alam, S. Babu, C. Navaneetha, S. Jyoshna, M. Ladle
article en

Abstract

The present prospective observational study evaluated the prescription pattern of drugs among patients attending the gastroenterology outpatient department of a tertiary care hospital. A total of 100 prescriptions were assessed over a six-month study period. Patient demographic characteristics, diagnosis, comorbidities, prescribed medicines, number of drugs, duration of therapy, dietary advice, follow-up advice, adverse reactions and lifestyle advice were recorded. Descriptive statistics were used and findings were expressed as frequencies and percentages. Patients aged 46–60 years constituted the largest age group (31%), followed by those above 60 years (28%) and 31–45 years (27%). Females represented 49% and males 51% of the study population. Normal body mass index was recorded in 71% of patients. Gastroesophageal reflux disease was the most frequent listed primary diagnosis (7%). Most patients (58%) received one to two drugs per prescription, while 21% received three to four, 14% received five to six and 7% received more than six drugs. Proton pump inhibitors were the most commonly reported drug category (26%), followed by gastrointestinal prokinetic agents (14%). Therapy continued for more than 30 days in 36% of prescriptions. Comorbidities were absent in 95% of patients. Follow-up was advised in 82%, while adverse reactions were reported in 1% of patients. Dietary advice was not documented in 62% of prescriptions, whereas 26% included a soft diet. The findings demonstrate predominant use of acid-suppressive therapy and variable degrees of polypharmacy, supporting the need for continued prescription review and rational drug-use monitoring in gastroenterology practice.

Zenodo (CERN European Organization for Nuclear Research)
Krishna Institute of Medical Sciences (IN)
Pharmaceutical Practices and Patient Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon